Last edition
News about "Bosutinib Tablets"
Dr. Reddy's Announces the First-to-Market Launch of Bosutinib Tablets 400 mg
Dr. Reddy’s has launched Bosutinib Tablets 400 mg in the US, becoming the first generic equivalent of Bosulif available in the market.
Bosutinib Tablets | 15/06/2026 | By News Bureau
Alembic Pharma Secures US FDA Tentative Approval for Bosutinib Tablets
The USFDA’s tentative approval confirms that Alembic Pharmaceuticals’ Bosutinib Tablets, 400 mg, meet therapeutic equivalence requirements with the Reference Listed Drug (RLD) Bosulif, marking an important step towards potential market entry.
Bosutinib Tablets | 12/01/2026 | By News Bureau | 221
Alembic Pharma Secures USFDA Tentative Approval for Bosutinib Tablets
Alembic Pharmaceuticals has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Bosutinib Tablets, 100 mg and 500 mg.
Bosutinib Tablets | 02/07/2024 | By Aishwarya | 992
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy